BJDX Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 1.19
- P/S (TTM)
- 54.99
- EV/EBITDA
- -0.10
Profitability & growth
- ROE (TTM)
- -171.6%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 0.82
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Bluejay Diagnostics Inc
Company profileBluejay Diagnostics Inc. is a forward-thinking medical technology company dedicated to transforming patient care through its innovative diagnostic solutions, emphasizing early disease detection. The firm employs a proprietary platform that integrates advanced artificial intelligence with point-of-care testing to enhance diagnostic accuracy and expedite results, empowering healthcare providers with crucial insights in real-time. With a strong commitment to research and development, Bluejay is strategically positioned to address significant healthcare challenges and meet the increasing demand…
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 360 MASSACHUSETTS AVENUE, ACTON, MA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer